Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...
AstraZeneca has begun a new agreement with Daiichi Sankyo to develop and market an antibody to treat cancer, worth up to $6 billion. The deal covers DS-1062, Daiichi Sankyo’s proprietary antibody-drug ...
Justice Secretary David Lammy has said he was "not equipped with all the detail" about a mistaken prisoner release when he appeared at PMQs, and said the Government had a "mountain to climb" in ...
DALLAS (AP) — Before Carson Beck's second interception put SMU in perfect position to beat No. 10 Miami in overtime, Marquise Lightfoot's critical penalty took away a chance for the Hurricanes to ...
Hey folks, first off, awesome library! I'm opening this issue to suggest a documentation improvement. I think it would be super helpful for new users to have a ...